Hb Calgary (

Autosomal dominant thalassemia hemoglobinopathies inclusion body thalassemia unstable hemoglobin (Hb) β-globin variant

Journal

Hemoglobin
ISSN: 1532-432X
Titre abrégé: Hemoglobin
Pays: England
ID NLM: 7705865

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 28 7 2021
medline: 17 3 2022
entrez: 27 7 2021
Statut: ppublish

Résumé

We describe two unrelated patients, both heterozygous for an unstable hemoglobin (Hb) variant named Hb Calgary (

Identifiants

pubmed: 34311670
doi: 10.1080/03630269.2021.1956947
doi:

Substances chimiques

Hemoglobins, Abnormal 0
beta-Globins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-219

Auteurs

Georgina Martin (G)

Department of Pediatric Hematology, University of Calgary, Calgary, Canada.

Runa M Grimholt (RM)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway.

Doan Le (D)

Department of Pediatric Hematology, University of Calgary, Calgary, Canada.

Anne G Bechensteen (AG)

Department of Paediatric Haematology and Oncology, Oslo University Hospital, Oslo, Norway.

Olav Klingenberg (O)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Bente Fjeld (B)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Thomas Fourie (T)

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.

Renee Perrier (R)

Department of Medical Genetics and Pediatrics, University of Calgary, Calgary, Canada.

Melanie Proven (M)

Oxford Molecular Diagnostics Centre, Oxford University Hospitals, National Health Service (NHS) Foundation Trust, Oxford, UK.
National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK.

Shirley J Henderson (SJ)

Oxford Molecular Diagnostics Centre, Oxford University Hospitals, National Health Service (NHS) Foundation Trust, Oxford, UK.
National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK.

Noémi B A Roy (NBA)

National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK.
Department of Haematology, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH